Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Clinical trial NCT06993844 · RECRUITING

Trial details

NCT number: NCT06993844
Sponsor: Ensem Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Advanced Breast Cancer

Start date: 2025-06-10
Primary completion: 2027-06-30
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.